CureVac's Series E Round

CureVac raised a round of funding on March 05, 2015.

CureVac, a German clinical stage biopharmaceutical company founded in 2000, is pioneering the field of mRNA-based technology platforms for medical purposes, in which unmodified mRNA is specifically op…

Articles about CureVac's Series E Round: